{"name": "PNP Therapeutics",
 "permalink": "pnp-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/pnp-therapeutics",
 "homepage_url": "http://www.pnptherapeutics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@PNPTherapeutics.com",
 "phone_number": "",
 "description": "",
 "created_at": "Sat Mar 20 07:59:01 UTC 2010",
 "updated_at": "Sat Mar 20 08:04:01 UTC 2010",
 "overview": "\u003Cp\u003EPNP Therapeutics is an early-stage, biopharmaceutical company engaged in the development of a platform technology and proprietary products for the treatment of cancer. At the center of PNP\u0026#8217;s Therapeutic System is a patented enzyme (E. coli purine nucleoside phosphorylase) that has been shown to work with a variety of well-characterized nucleoside prodrugs generating active metabolites with high levels of anti-tumor activity. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       50],
      "assets/images/resized/0008/1071/81071v1-max-150x150.jpg"],
     [[250,
       83],
      "assets/images/resized/0008/1071/81071v1-max-250x250.jpg"],
     [[294,
       98],
      "assets/images/resized/0008/1071/81071v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$925k",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.southernresearch.org/pdf/PNPFunding-6-7-07.pdf",
    "source_description": "PNP Therapeutics Raises $925,000 in Series B Financing through Birmingham Technology Fund and Phase 1 Holdings",
    "raised_amount": 925000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 6,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Greer Capital Advisors",
         "permalink": "greer-capital-advisors",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0008/1075/81075v1-max-150x150.jpg"],
             [[250,
               73],
              "assets/images/resized/0008/1075/81075v1-max-250x250.jpg"],
             [[280,
               82],
              "assets/images/resized/0008/1075/81075v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "4363 1st Avenue North",
    "address2": "",
    "zip_code": "35222",
    "city": "Birmingham",
    "state_code": "AL",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        77],
       "assets/images/resized/0008/1073/81073v1-max-150x150.jpg"],
      [[250,
        128],
       "assets/images/resized/0008/1073/81073v1-max-250x250.jpg"],
      [[450,
        231],
       "assets/images/resized/0008/1073/81073v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}